SWM
WST icon

SHP Wealth Management’s West Pharmaceutical WST Stock Holding History

SHP Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5K Buy
+6
New +$1.49K ﹤0.01% 1362

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHP Wealth Management's WST Position: Q1 2026 in Review

SHP Wealth Management opened a new position in West Pharmaceutical (WST) in Q1 2026: 6 shares worth $1.5K. The stake represents ﹤0.01% of the portfolio and ranks #1362 among its holdings.

754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • SHP Wealth Management held 6 shares of West Pharmaceutical worth $1.5K as of Q1 2026.
  • West Pharmaceutical was a new SHP Wealth Management position in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1362 holding.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.